TORONTO–( BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its shares commence trading on the OTCQB® Venture Market (the “OTCQB”) on March 8, 2021, under the symbol “CLXPF.” The OTCQB, operated by OTC Markets Group Inc., is designed for developing and entrepreneurial…


Previous articleBetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies
Next articlePsychedelic Speech: How Drugs Disorganize Normal Communication Patterns